ClinicalTrials.gov
public full text
Public Domain
UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia
The primary objective of this study is to evaluate two different ultraviolet (UV) dosing regimens for corneal collagen cross linking to slow the progressive changes in corneal curvature in eyes with progressive keratoconus or post-refractive surgery ectasia.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Riboflavin-UVA Induced Collagen Crosslinking Treatment for Corneal Ectasia#1007252
- Corneal Collagen Cross-linking With Hypotonic Riboflavin in Corneas Thinner Than 400 Microns#992526
- Clinical and Structural Outcome of Conventional Versus Accelerated Corneal Collagen Cross-linking (CXL).#842789
- Topo-Pachymetric Customized Accelerated Epi-On Vs Accelerated Epi-Off Corneal Cross Linking in Keratoconus Management#842378
- Efficacy of Customized Corneal Cross-linking vs. Standard Corneal Cross-linking#1307345
Record · ID 1384111
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive